Analyst Expect Big Moves From Repligen Corp. (NASDAQ: RGEN)
BlackRock Fund Advisors recently announced the acquisition of new stake in Repligen Corp. (NASDAQ:RGEN). The institutional investor has increased its shareholding in the Healthcare company by 0.00% to 4.96 million shares with purchase of 97.0 shares. This fresh investment now brings its stake to 8.88% valued currently at $890.91 million. In addition, T. Rowe Price […]